cro.directory
← Compare landing

BioAgilytix vs ICON plc

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBioAgilytixICON plc
SummaryBioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
Services
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Virology Services
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Companion Diagnostics Development
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Ophthalmology
  • Women's Health
Phases
  • Discovery
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Research Triangle Park Campus (US Headquarters), Durham, North Carolina, United States
  • Morrisville Labs, Morrisville, North Carolina, United States
  • Boston Laboratory, Boston, Massachusetts, United States
  • San Diego Laboratory, San Diego, California, United States
  • Hamburg Laboratory (EU Headquarters), Hamburg, Hamburg, Germany
  • Brisbane Laboratory, Brisbane, Queensland, Australia
  • Melbourne Laboratory (Australian Headquarters), Melbourne, Victoria, Australia
  • Partner Labs, Beijing, Beijing, China
  • Headquarters, Dublin, Ireland
  • Belgium, Belgium, Belgium
  • Bulgaria, Bulgaria, Bulgaria
  • Germany, Germany, Germany
  • Hungary, Hungary, Hungary
  • Italy, Italy, Italy
  • Netherlands, Netherlands, Netherlands
  • Poland, Poland, Poland
  • Romania, Romania, Romania
  • Slovakia, Slovakia, Slovakia
  • South Africa, South Africa, South Africa
  • Spain, Spain, Spain
  • Türkiye, Türkiye, Türkiye
  • United Kingdom, United Kingdom, United Kingdom
  • Australia, Australia, Australia
  • China, China, China
  • India, India, India
  • Japan, Japan, Japan
  • Korea, Korea, Korea
  • Malaysia, Malaysia, Malaysia
  • Taiwan, Taiwan, Taiwan
  • Argentina, Argentina, Argentina
  • Brazil, Brazil, Brazil
  • Chile, Chile, Chile
  • Colombia, Colombia, Colombia
  • Mexico, Mexico, Mexico
  • Belgium, Belgium, Belgium
  • Bulgaria, Bulgaria, Bulgaria
  • Germany, Germany, Germany
  • Hungary, Hungary, Hungary
  • Italy, Italy, Italy
  • Netherlands, Netherlands, Netherlands
  • Poland, Poland, Poland
  • Romania, Romania, Romania
  • Slovakia, Slovakia, Slovakia
  • South Africa, South Africa, South Africa
  • Spain, Spain, Spain
  • Türkiye, Türkiye, Türkiye
  • United Kingdom, United Kingdom, United Kingdom
  • Australia, Australia, Australia
  • China, China, China
  • India, India, India
  • Japan, Japan, Japan
  • Korea, Korea, Korea
  • Malaysia, Malaysia, Malaysia
  • Taiwan, Taiwan, Taiwan
  • Argentina, Argentina, Argentina
  • Brazil, Brazil, Brazil
  • Chile, Chile, Chile
  • Colombia, Colombia, Colombia
  • Mexico, Mexico, Mexico
  • United States, United States, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

BioAgilytix alternatives · ICON plc alternatives

Markdown mirror: /compare/bioagilytix/iconplc.md